# Nuclide record illuccix (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/illuccix/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "illuccix" ;
  schema:name "Illuccix (kit for Ga-68 gozetotide)"@en ;
  schema:description "Telix's ready-to-label kit that lets any nuclear medicine department make the gallium PSMA scan for prostate cancer."@en ;
  schema:url <https://nuclide.cc/drugs/illuccix/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Illuccix> ;
  nuclide:status "approved" ;
  nuclide:tag "test" ;
  nuclide:modality "PET imaging agent kit (PSMA, gallium-68)" ;
  schema:alternateName "Illuccix / Gozellix" ;
  nuclide:approval "US 2021: PSMA PET imaging in prostate cancer (initial staging with suspected metastasis; suspected recurrence)", "Australia 2021: PSMA PET imaging in prostate cancer", "US 2025: Gozellix kit; selection of patients for PSMA-targeted radioligand therapy" ;
  nuclide:related <https://nuclide.cc/drugs/ga68-psma-11/>, <https://nuclide.cc/drugs/locametz/>, <https://nuclide.cc/drugs/pylarify/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:drugs <https://nuclide.cc/drugs/pluvicto/> ;
  nuclide:companies <https://nuclide.cc/companies/telix/> ;
  nuclide:terms <https://nuclide.cc/terms/biochemical-recurrence/>, <https://nuclide.cc/terms/theranostics/> .